Skip to main content
MEMPHASYS LIMITED. logo

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2008-07-20 Director's Dealing
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
NuSep Increase in Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's personal share transactions, including the number of shares acquired, disposed, and the nature of the transaction (purchase on market). There is no financial performance data, management discussion, or regulatory filing beyond director share dealings. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3026 characters, which is consistent with a detailed director dealing notice rather than a full report or announcement of a report.
2008-07-20 English
NuSep Increase in Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details changes in a director's shareholdings, including number of shares acquired and disposed, dates of changes, and nature of transactions. It references ASX listing rules and the Corporations Act, indicating it is a regulatory disclosure of insider trading by a director. There is no financial performance data, no report or announcement of financial results, no meeting materials, and no other corporate event described. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on director share transactions, confirming it is not a broader report or announcement.
2008-07-15 English
NuSep Increase in Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's acquisition of shares, including the number of shares before and after the transaction, the date of change, and the nature of the transaction (purchase on market). This is a report of personal share transactions by a company director. It does not contain financial statements, management discussion, or other report content. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused solely on insider share transactions, confirming this classification with high confidence.
2008-07-13 English
Response to ASX Appendix 3Y Query 3 pages ?Kb
Regulatory Filings
2008-07-09 English
Appendix 3B - Issues shares under $1.75m SPP and Placement 10 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is a press release and official announcement from NuSep regarding the issuance of shares under a Share Purchase Plan (SPP) and a share placement, including details of the securities issued, their terms, and the application for quotation of these additional securities on the ASX. It includes an Appendix 3B form, which is a standard regulatory form used in Australian markets to announce new issues of securities and related information. The document does not contain financial statements, management discussion, or detailed financial results, but rather focuses on capital raising and share issuance activities. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a report publication announcement, but a substantive update on capital raising.
2008-07-09 English
NuSep Raises $1.75m via SPP and Placement 1 page ?K
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that NuSep has raised $1.75 million through a Share Purchase Plan and a share placement. It provides details about the fundraising amounts, the closing date of the SPP, and mentions a research report by DFS Equities. The document also includes company background and product information but does not contain any financial statements, detailed financial analysis, or regulatory filing references. The length is short (2846 characters) and the content is focused on capital raising activity. Therefore, this document fits best under the category of Capital/Financing Update (CAP).
2008-07-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.